NovImmune

NovImmune

NovImmune

NovImmmune develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders.
Founded
1998
Raised
$137.2M
Follow us
Alexa global traffic share
Latest funding Show all
$22,413,980
Venture capital (Series D) - 2010
BZ Bank
$54,800,000
Venture capital (Series C) - 2009
Novartis Venture Fund Aravis Ventures BZ Bank +4
Team Size
50+
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when NovImmune makes some noise.